
Not for distribution, directly or indirectly, in or into 
                                                                                                                        
Further to the pre-stabilisation period announcement dated 
| The securities: | |
| Issuer: |  | 
| Securities: | Ordinary bearer shares with no par value of the Issuer (ISIN: DE000BCK2223) | 
| Base Offer Shares: | 10,640,151 ordinary bearer shares (excluding the over-allotment option) | 
| Offer price |  | 
| Stabilisation: | |
| Stabilisation Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052): | Goldman Sachs Bank Europe SE, Taunusanlage 9-10, 60329 Frankfurt am Main, Germany | 
| Stabilisation started: |  | 
| Stabilisation last occurred: |  | 
| Stabilisation trading venues: |  | 
Stabilisation transactions:
| Trading Date | Lowest price (EUR) | Highest price (EUR) | Trading venue | 
|  | 66.00 | 66.00 | XETRA | 
|  | 65.60 | 66.00 | XETRA | 
|  | 65.40 | 66.00 | XETRA | 
|  | 64.50 | 65.50 | XETRA | 
|  | 63.50 | 64.30 | XETRA | 
|  | 65.00 | 66.00 | XETRA | 
Disclaimer and Other Notices
This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.
This announcement and the information contained herein, is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.
In member states of the European Economic Area ("EEA"), in which the Regulation (EU) 2017/1129 as amended (the "Prospectus Regulation") is in effect other than Germany (the "Relevant Member States"), this announcement is only addressed to persons who are 'qualified investors' within the meaning of Article 2(e) of the Prospectus Regulation ("
This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the 
If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the 
Solely for the purpose of the product governance requirements contained within; (a) EU Directive 2014/65/EU of the European Parliament and of the Council of 
For the avoidance of doubt, the Target Market Assessment does not constitute; (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Offer Shares.
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the
